Tonix Pharma (TNXP)

Tonix Pharma (TNXP) Financial Statements


Tonix Pharma Financial Overview

Tonix Pharma's market cap is currently ―. The company's EPS TTM is $-11.23; its P/E ratio is -0.03; Tonix Pharma is scheduled to report earnings on March 11, 2024, and the estimated EPS forecast is $-1.46. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue$ 3.99M---$ 0.00
Gross Profit$ 1.61M----
EBIT$ -25.60M$ -28.36M$ 34.80M$ -32.73M$ -29.59M
EBITDA$ -24.39M$ -27.43M$ 35.69M$ -33.82M$ -29.34M
Net Income Common Stockholders$ -27.98M$ -28.36M$ 34.80M$ -34.08M$ -28.98M
Balance Sheet-
Cash Cash Equivalents And Short Term Investments$ 6.91M$ 25.62M$ 71.97M$ 120.23M$ 139.98M
Total Assets$ 139.28M$ 159.74M$ 179.09M$ 225.69M$ 242.65M
Total Debt$ 1.15M$ 1.27M$ 1.03M$ 760.00K$ 886.00K
Net Debt$ -5.76M$ -24.35M$ -70.95M$ -119.47M$ -139.09M
Total Liabilities$ 18.45M$ 19.27M$ 13.66M$ 18.51M$ 13.72M
Stockholders Equity$ 120.83M$ 140.46M$ 165.43M$ 207.18M$ 228.92M
Cash Flow-
Free Cash Flow$ -24.21M$ -25.22M$ -36.70M$ -26.97M$ -32.35M
Operating Cash Flow$ -23.39M$ -23.37M$ -32.91M$ -22.30M$ -23.54M
Investing Cash Flow$ -821.00K$ -24.02M$ -3.80M$ -4.67M$ -8.82M
Financing Cash Flow$ 6.27M$ 1.03M$ -11.50M$ 7.23M$ -4.63M
Currency in USD

Tonix Pharma Earnings and Revenue History

Tonix Pharma Debt to Assets

Tonix Pharma Cash Flow

Tonix Pharma Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis